The current Coronavirus disease 2019 or COVID-19 pandemic has infected over two million
people and resulted in the death of over one hundred thousand people at the time of writing …

A novel coronavirus SARS-CoV-2 causing Coronavirus disease 2019 (COVID-19) has
entered the human population and has spread rapidly around the world in the first half of …

Background This is the first randomised controlled trial for assessment of the
immunogenicity and safety of a candidate non-replicating adenovirus type-5 (Ad5)-vectored …

Since the end of 2019, coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide. The RNA …

Abstract The SARS-CoV-2, previously called a novel coronavirus, that broke out in the
Wuhan city of China caused a significant number of morbidity and mortality in the world. It is …

As vacinas candidatas contra COVID-19 têm diversas composições, desde vacinas de vírus
inativados a várias de nova geração. Atualmente, cerca de 175 equipes de pesquisa em …

Abstract The coronavirus disease 2019 (COVID-19) pandemic that hit the world in 2020
triggered a massive dissemination of information (an “infodemic”) about the disease that was …

Abstract Background The Covid-19 pandemic is causing unprecedented disruption and
suffering to people across the globe, with a disproportionate toll on the elderly. The …

B cells produce detectable antibodies in classes IgM, IgG, and IgA along with lesser
amounts of IgD and IgE. For SARS-CoV-2, the causative agent of covid-19, the focus is …

A year after the initial outbreak of Covid-19 pandemic, several Phase III clinical trials
investigating vaccine safety and efficacy have been published. These vaccine candidates …